Ye Wu

1.7k total citations
54 papers, 1.2k citations indexed

About

Ye Wu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ye Wu has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Ye Wu's work include Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (8 papers) and Chemical Synthesis and Analysis (8 papers). Ye Wu is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (8 papers) and Chemical Synthesis and Analysis (8 papers). Ye Wu collaborates with scholars based in China, United States and United Kingdom. Ye Wu's co-authors include Xin Luan, Hongzhuan Chen, Jinmei Jin, Lijun Zhang, Yiwen Shen, Rui Huang, Hong Zhang, Weidong Zhang, Dale G. Nagle and Yudong Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis B: Environmental and Chemical Engineering Journal.

In The Last Decade

Ye Wu

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Wu China 17 692 268 167 126 121 54 1.2k
Rongsheng E. Wang United States 22 976 1.4× 247 0.9× 188 1.1× 222 1.8× 167 1.4× 40 1.4k
Michael Weinmüller Germany 11 509 0.7× 201 0.8× 179 1.1× 118 0.9× 81 0.7× 13 884
Andreas F. B. Räder Germany 11 509 0.7× 177 0.7× 196 1.2× 129 1.0× 80 0.7× 13 887
E. K. RYU South Korea 17 538 0.8× 128 0.5× 203 1.2× 77 0.6× 94 0.8× 63 1.1k
Sara La Manna Italy 20 546 0.8× 279 1.0× 139 0.8× 94 0.7× 43 0.4× 64 1.2k
Annarita Del Gatto Italy 20 517 0.7× 129 0.5× 77 0.5× 83 0.7× 42 0.3× 38 851
Barbara Richichi Italy 20 689 1.0× 166 0.6× 374 2.2× 103 0.8× 45 0.4× 69 1.3k
Tomoka Takatani‐Nakase Japan 19 1.1k 1.6× 140 0.5× 84 0.5× 110 0.9× 116 1.0× 46 1.6k
Jianfeng Cai United States 19 844 1.2× 190 0.7× 309 1.9× 93 0.7× 312 2.6× 37 1.3k

Countries citing papers authored by Ye Wu

Since Specialization
Citations

This map shows the geographic impact of Ye Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wu more than expected).

Fields of papers citing papers by Ye Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wu. The network helps show where Ye Wu may publish in the future.

Co-authorship network of co-authors of Ye Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Wu. A scholar is included among the top collaborators of Ye Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Wu. Ye Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Weidong, et al.. (2025). The Transmission of Herbal Medicine to China via the Silk Road in Medieval Ages. SHILAP Revista de lepidopterología. 8(1). 13–23.
2.
Lin, Jiayi, Ye Wu, Min Tang, et al.. (2025). A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy. Advanced Science. 12(23). e2500311–e2500311. 3 indexed citations
3.
Liang, Xiaohui, Lu Dong, Jiayi Lin, et al.. (2024). In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77‐PPARγ Interaction and Its Anti‐Breast‐Cancer Efficacy. Advanced Science. 11(26). e2308435–e2308435. 7 indexed citations
4.
Wu, Ye, Jiayi Lin, Yudong Zhou, et al.. (2024). Oncolytic Peptide‐Nanoplatform Drives Oncoimmune Response and Reverses Adenosine‐Induced Immunosuppressive Tumor Microenvironment. Advanced Healthcare Materials. 13(26). e2303445–e2303445. 11 indexed citations
5.
Zhang, Xiao-kun, Ye Wu, Jiayi Lin, et al.. (2024). Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges. Acta Pharmaceutica Sinica B. 14(9). 3818–3833. 12 indexed citations
6.
Luo, Xiaofang, Ye Wu, Xiao-kun Zhang, et al.. (2024). Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters. 36(1). 109724–109724. 11 indexed citations
7.
Jin, Jinmei, Ye Wu, Jiayi Lin, et al.. (2024). Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy. Bioactive Materials. 43. 255–272. 11 indexed citations
8.
Liu, Xiaoxia, Ting Yang, Jiayi Lin, et al.. (2023). [Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].. PubMed. 48(18). 4981–4992. 1 indexed citations
9.
Gu, Wenjie, Yuan Hu, Yudong Zhou, et al.. (2023). Crizotinib‐based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation. Cancer Science. 114(5). 1958–1971. 12 indexed citations
10.
Lin, Jiayi, Haijun Liu, Ye Wu, et al.. (2023). Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer. Small. 19(18). e2207778–e2207778. 24 indexed citations
11.
Wu, Ye, Ling‐Ling Chen, Feng Cheng, et al.. (2023). Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3. BMC Oral Health. 23(1). 846–846. 1 indexed citations
12.
Jin, Jinmei, Yaping Wu, Ye Wu, et al.. (2022). Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. JCI Insight. 7(22). 41 indexed citations
13.
Wu, Ye, et al.. (2022). The proteolysis targeting chimera GMB-475 combined with dasatinib for the treatment of chronic myeloid leukemia with BCR::ABL1 mutants. Frontiers in Pharmacology. 13. 931772–931772. 2 indexed citations
14.
Zhang, Lijun, Rui Huang, Yiwen Shen, et al.. (2021). Enhanced anti-tumor efficacy by inhibiting HIF-1α to reprogram TAMsviacore-satellite upconverting nanoparticles with curcumin mediated photodynamic therapy. Biomaterials Science. 9(19). 6403–6415. 30 indexed citations
15.
Huang, Rui, Lijun Zhang, Jinmei Jin, et al.. (2021). Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharmaceutica Sinica B. 11(11). 3481–3492. 51 indexed citations
16.
Wu, Ye, Lu Dong, Yixin Jiang, et al.. (2021). Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma. Journal of Medicinal Chemistry. 64(9). 5802–5815. 37 indexed citations
17.
Lin, Jiayi, Jinmei Jin, Yiwen Shen, et al.. (2021). Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins. Theranostics. 11(17). 8337–8349. 61 indexed citations
18.
Wu, Ye, Rui Huang, Jinmei Jin, et al.. (2020). Advances in the Study of Structural Modification and Biological Activities of Anoplin. Frontiers in Chemistry. 8. 519–519. 23 indexed citations
19.
Jin, Jinmei, Ye Wu, Yiwen Shen, et al.. (2020). The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination. Theranostics. 10(22). 10141–10153. 100 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongsheng E. Wang Breakdown of academic impact, for papers by Michael Weinmüller Breakdown of academic impact, for papers by Andreas F. B. Räder Breakdown of academic impact, for papers by E. K. RYU Breakdown of academic impact, for papers by Sara La Manna Breakdown of academic impact, for papers by Annarita Del Gatto Breakdown of academic impact, for papers by Barbara Richichi Breakdown of academic impact, for papers by Tomoka Takatani‐Nakase Breakdown of academic impact, for papers by Jianfeng Cai
Rankless by CCL
2026